Strata Critical Medical, Inc.

SRTA Healthcare Medical Care Facilities

Revenue
+50.3%
EPS
−112.3%
Free cash flow
+121.3%

Quarter to September 2026, against a year earlier

5.57 0.31 +5.89%
Market cap
$469.8M
P/E
0.0×
Fwd P/E
−48.0×
Dividend yield
—
F-score
5/9
Altman Z
5.25
Beneish M
−0.84
Dividend safety
n/a

Insider Decisions last twelve months

Bought, $m 0.10
Sold, $m 0.83
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy 2 — — — — — — — — — — —
Sell — — — — — 2 4 — 1 — — —
Insider Ownership 24.19%

Capital & Financial Ratios $m

Size
Market Cap 469.82
Revenue ttm 280.76
Net income ttm (24.81)
Free cash flow ttm (0.38)
Net debt Q (41.91)
Valuation
P/E 0.00
Forward P/E (48.00) (negative: loss-making)
Price / sales 1.75
Forward P/S Powerpack
Price / FCF 0.00
Price / book 1.78
Financial health
Current ratio Q 2.77 (at or above 1.5: strong)
Debt / equity Q 0.00 (at or below 0.5: strong)
Interest coverage Q —
Growth
Revenue growth Q +50.27% (above 0%: growing)
Operating income growth Q +31.86% (above 0%: growing)
EPS, this year +56.46% (at or above 15%: strong)
EPS, next year A +177.27% (at or above 15%: strong)
Revenue, next year A +47.51% (at or above 10%: strong)
EPS, past 5 yrs —
EPS, next 5 yrs A +55.32% (at or above 15%: strong)

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

P/S against its own 10 years 45.25%
10-year low 10-year high
P/B against its own 10 years 71.78%
10-year low 10-year high
EV/Sales against its own 10 years 71.07%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 167 125 61 42
Receivables 21 20 40 43
Inventory — — — —
Other — — — —
206 161 126 125
2023 2024 2025 Q'26
Payables 24 9 19 14
ST’ Debt — — — —
Other — — — 30
35 23 20 45

Compound Annual Growth %

10y 5y 3y
Sales — 31.30% 10.50%
Cash Flow — 0.00% 0.00%
Earnings 0.00% 0.00% 0.00%
Book Value — (0.85%) 0.55%

Earnings Trends EPS, adjusted, against the consensus

EPS $

Mar Jun Sep Dec Year
’26 0.03 (0.12) (0.09) — —
’25 (0.04) (0.05) 0.70 (0.10) 0.50
’24 (0.06) (0.15) (0.03) (0.12) (0.35)
’23 (0.14) (0.17) 0.00 (0.45) (0.76)
’22 (0.16) 0.10 (0.13) (0.21) (0.38)
’21 — — — 0.01 (0.93)
’21 (0.16) (0.47) (0.13) — (0.93)
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 67 73 74 — —
’25 36 45 49 67 197
’24 — — 36 36 147
’23 45 61 71 47 225
’22 27 36 46 38 146
’21 — — — 33 75
’21 9 13 20 17 51
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 4 6 9 — —
’25 0 (3) (37) (8) (49)
’24 (16) 8 6 (2) (3)
’23 (17) (8) 2 (9) (32)
’22 (10) (12) (6) (9) (37)
’21 — — — (6) (22)
’21 (1) (9) (6) — (16)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (2) 3 9 — —
’25 (3) (6) (40) (10) (60)
’24 (17) (8) (4) (7) (35)
’23 (18) (9) 1 (9) (34)
’22 (11) (12) (6) (9) (38)
’21 — — — (19) (35)
’21 (1) (9) (6) — (16)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Sep ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue — — 31 31 23 75 146 225 147 197 281 +30.1% 291 326 318 +17.3%
Gross margin, % — — 15.06 15.06 9.93 19.24 15.24 18.71 20.15 20.86 21.57 +5.8 pt
EBT — — (11) 1 0 (43) (28) (58) (16) (20) (21) +9.2%
EBT margin, % — — (34.74) 0.00 0.00 (57.27) (19.18) (25.55) (11.01) (10.18) (7.52) +24.6 pt
Net income — 0 0 1 0 (39) (27) (56) (27) 41 (25) n/m
Per share, $
Per share, $ Revenue — — 0.00 0.00 0.00 1.75 2.05 3.06 1.89 2.40 3.18 n/m
Earnings — — — 0.11 (2.17) (0.93) (0.38) (0.76) (0.35) 0.50 (0.28) +28.8%
Cash flow — — — (0.04) (0.10) (0.50) (0.52) (0.44) (0.03) (0.60) 0.12 +59.8%
Capex — — — 0.00 0.00 (0.30) (0.01) (0.03) (0.43) (0.13) (0.13) n/m
Free cash flow — — — (0.04) (0.10) (0.80) (0.53) (0.47) (0.46) (0.73) 0.00 +65.3%
Book value — — 0.00 0.70 0.61 6.79 3.85 3.19 2.86 3.40 3.13 n/m
Shares, m — — — 7 8 43 71 74 77 82 85 +50.1%
Valuation, ×
Valuation, × P/E — — 491.50 491.50 15.45 0.00 0.00 0.00 0.00 9.49 0.00 126.0
P/S — — 0.00 0.00 0.00 5.04 1.65 1.11 1.72 2.00 1.75 1.4
P/B — — 12.72 12.72 7.45 1.30 0.88 1.07 1.48 1.41 1.78 4.9
EV/Sales — — 0.00 0.00 0.00 1.28 0.31 0.37 1.07 1.69 1.60 0.6
EV/FCF — — 0.00 0.00 (104.74) (4.34) (1.20) (2.43) (5.75) (5.56) (1,177.43) (15.5)
Cash, $m
Cash, $m Operating cash flow — — — 0 (1) (22) (37) (32) (3) (49) 11 +139.9%
Capex — — — (1) 0 (13) (1) (2) (33) (11) (11) +62.2%
Free cash flow — — — 0 (1) (35) (38) (34) (35) (60) 0 +148.2%
Balance, $m
Balance, $m Working capital — — 275 1 1 282 192 171 138 106 80 (12.7%)
Net debt — — (276) (1) (1) (283) (195) (167) (125) (61) (42) (19.3%)
Shareholders’ equity — — 5 5 5 291 274 234 222 279 276 +77.6%
Returns, %
Returns, % ROA — — (7.88) 0.28 0.09 (11.57) (8.25) (18.09) (9.90) 14.21 (7.47) +22.1 pt
ROIC — — 0.00 (4.54) (10.21) (246.73) (42.17) (63.53) (14.54) (6.42) (4.96) (6.4) pt
ROE — — 0.00 27.13 1.59 (13.48) (9.63) (22.04) (11.97) 16.51 (8.87) +16.5 pt
People
People Employees — — — — — 133 246 281 322 601 — +45.8%
Revenue/emp, $m — — 0.00 0.00 0.00 0.00 0.59 0.80 0.46 0.33 — n/m
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated 5 Nov 2026

Strata Critical Medical, Inc. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
NUTX Nutex Health Inc. $1.3B 6.9× 7.3× −13.62% (below 0%: shrinking) n/m +19.44% (above 0%: growing) 67.04% 57.75% Compare
INNV InnovAge Holding Corp. $1.2B 124× 20.9× +12.14% (above 0%: growing) +155.00% (above 0%: growing) +622.82% (above 0%: growing) 24.02% 7.61% Compare
CMPS COMPASS Pathways PLC Sponsored ADR $1.1B — (loss-making) — — n/m −44.62% (below 0%: shrinking) — 0.00% Compare
GMRS GMR Solutions Inc. $675.8M 15.8× — — n/m — 100.00% 3.80% Compare
STLN Starling Oncology, Inc. $669.9M — (loss-making) — (loss-making) +24.31% (above 0%: growing) n/m +167.10% (above 0%: growing) 0.00% (1.76%) Compare
MCTA Charming Medical Limited $497.3M — — — — — — — Compare
SRTA Strata Critical Medical, Inc. $469.8M — (loss-making) — (loss-making) +50.27% (above 0%: growing) n/m +121.34% (above 0%: growing) 22.70% (5.17%)
AUNA Auna S.A. $339.7M 66.7× 6.1× +20.51% (above 0%: growing) −61.29% (below 0%: shrinking) +121.08% (above 0%: growing) 35.72% 13.09% Compare
CYH Community Health Systems, Inc. $321.5M 4.2× — (loss-making) −10.69% (below 0%: shrinking) n/m +857.14% (above 0%: growing) 85.24% 5.30% Compare
Median of peers $672.8M 15.8× 7.3× +12.14% — +144.09% 51.38% 5.30%

All 51 Medical Care Facilities stocks →

Pay and ownership Proxy statement filed 14 April 2026

Ownership

Directors and executive officers, together 15.50%
Steele ExpCo Holdings, LLC 13.70%
Robert S. Wiesenthal 8.70%
ARK Investment Management LLC 7.40%
Third Point LLC 5.80%
BlackRock, Inc. 5.10%
Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

Strata Critical Medical, Inc. (SRTA) Latest News

3 Nov

11 Aug

Impact 3 · · The Motley Fool transcript

2 Jun

Impact 4 · · GlobeNewswire

6 May

Impact 3 · · The Motley Fool transcript

30 Apr

Impact 4 · · GlobeNewswire

3 Mar

Impact 4 · · The Motley Fool transcript

3 Dec

Impact 3 · · GlobeNewswireMT NewswiresMT NewswiresMedTech DiveMT NewswiresSimply Wall St.MT Newswires

19 Nov

Impact 4 · · Simply Wall St.Simply Wall St.
stockrow.com/SRTA · Data as of Nov 5, 2026 · For information only; not investment advice. · © 2026 stockrow.com